Dozens were still unaccounted for after a plane crash near Reagan Airport that happened Wednesday. President Trump signs aviation safety executive order A Recent IRS Ruling Could Affect Your ...

The Canadian dollar rose to a near three-week high against its U.S. counterpart on Monday, as investors weighed the potential for Canada's economy to escape broad-based U.S. tariffs and a report ...

Shares of Cameco (NYSE: CCJ) climbed 1.9% in pre-open trading Tuesday as the market responded to news of a new nuclear power ...

The Chalk River Nuclear Facility is cited as the largest supplier of medical radioisotopes in the world. (Chalk River was ...

Stocks across Asia lost ground on Monday as worries about Chinese AI company DeepSeek reverberated. The company's discounted R1 model knocked tech stocks, sending the Nikkei ( ^N225) in Japan 0.9% ...

Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles ...

Forbes has released its list of Canada’s best employers of 2025, highlighting the top 300 organizations where people actually ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

GSK PLC GSK shares shed 2.82% to £12.94 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.28% to 8,201.54. Supported by ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.